Vivos Inc (RDGL)
Vivos Inc. is a healthcare company listed on OTC Markets under the ticker RDGL. As a common stock issuer in the healthcare equipment and supplies segment, the company develops radiation oncology medical devices focused on brachytherapy and precision radionuclide therapy. Its work includes RadioGel, an yttrium-90 based injectable particle-gel under development for treating cancerous tumors in people and animals, as well as IsoPet, a product intended for solid tumor treatment in animals. Vivos is also advancing additional products and technologies under names including Alpha-Gel, Beta-Gel, Gamma-Gel, Precisiongel, a hydrogel, and a universal laboratory cooling device. The company, formerly known as Advanced Medical Isotope Corporation, adopted its current name in December 2017 and was incorporated in 1994. It is headquartered in Kennewick, Washington.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-RDGL
|
$0.039
|
-31.5% Downside
|
Overvalued
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 13, 2026
|
-8.7x
|
-4.5x
|
381.4x
|
28.66 M
|
36.567 M
|
0.3%
|
95.5%
|
23.2
|
—
|
66.9%
|
